Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 6Prostatic Neoplasms 4Colorectal Neoplasms 4Colonic Neoplasms 4Radiodermatitis 2Pancreatic Neoplasms 2Pain 2Neoplasms 2Multiple Myeloma 2Breast Carcinoma In Situ 2Adenomatous Polyposis Coli 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Stomatitis 1Smoldering Multiple Myeloma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycystic Ovary Syndrome 1Neoplasm Metastasis 1Monoclonal Gammopathy of Undetermined Significance 1Leukemia, Lymphocytic, Chronic, B-Cell 1Head and Neck Neoplasms 1Fatigue 1Endometrial Neoplasms 1Condylomata Acuminata 1Carcinoma, Intraductal, Noninfiltrating 1Carcinoma 1Adenocarcinoma 1

Interventions

Carboplatin 27Paclitaxel 23Cisplatin 22Gemcitabine 17pembrolizumab 15Fluorouracil 9Pemetrexed 8Everolimus 8Docetaxel 8Cetuximab 8Radiotherapy, Intensity-Modulated 7Radiotherapy 7130-nm albumin-bound paclitaxel 7Sorafenib 6Nivolumab 6Bevacizumab 6Axitinib 6epothilone B 5Sunitinib 5Radiation 5Panitumumab 5Cyclophosphamide 5trebananib 4reolysin 4padeliporfin 4lenvatinib 4Irinotecan 4Gefitinib 4vosaroxin 3volociximab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Carcinoma × Curcumin × Clear all
NCT00192842 2010-09-22

Gemcitabine With Curcumin for Pancreatic Cancer

Rambam Health Care Campus

Phase 2 Completed
17 enrolled
Gastrointestinal

Carcinoma, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡